Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Jahng, James W S  [Clear All Filters]
Journal Article
Mondéjar-Parreño G, Jahng JWS, Belbachir N, Wu BC, Zhang X, Perez MV, Badhwar N, Wu JC. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome. Stem Cell Res. 2021;54:102402.
Cao X, Jahng JWS, Lee C, Zha Y, Wheeler MT, Sallam K, Wu JC. Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations. Stem Cell Res. 2021;55:102455.
Jahng JWS, Black KE, Liu L, Bae HRyeong, Perez M, Ashley EA, Sallam K, Wu JC. Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene. Stem Cell Res. 2021;53:102284.
Zhang H, Jahng JWS, Liu Y, Chase AJ, Perez MV, Wu JC. Generation of three induced pluripotent stem cell lines (SCVIi014-A, SCVIi015-A, and SCVIi016-A) from patients with LQT1 caused by heterozygous mutations in the KCNQ1 gene. Stem Cell Res. 2021;55:102492.
Liu L, Shenoy SP, Jahng JWS, Liu Y, Knowles JW, Zhuge Y, Wu JC. Generation of two heterozygous MYBPC3 mutation-carrying human iPSC lines, SCVIi001-A and SCVIi002-A, for modeling hypertrophic cardiomyopathy. Stem Cell Res. 2021;53:102279.
Chen G, Orozco L, Parmisano S, Jahng JWS, Vera CD, Zhuge Y, Wu JC, Obal D. Generation of two induced pluripotent stem cell lines from patients suffering from pulmonary hypertension. Stem Cell Res. 2023;72:103218.
Manhas A, Jahng JWS, Vera CD, Shenoy SP, Knowles JW, Wu JC. Generation of two iPSC lines from hypertrophic cardiomyopathy patients carrying MYBPC3 and PRKAG2 variants. Stem Cell Res. 2022;61:102774.
Guo H, Yu X, Liu Y, Paik DT, Justesen JMarie, Chandy M, Jahng JWS, Zhang T, Wu W, Rwere F, et al. SGLT2 inhibitor ameliorates endothelial dysfunction associated with the common alcohol flushing variant. Sci Transl Med. 2023;15(680):eabp9952.